Applications Being Accepted for the 2025 Ramin Tadayoni Award
Oculis, in collaboration with EURETINA, announced that applications are now being accepted for the 2025 Ramin Tadayoni Award.
The Ramin Tadayoni Award continues its legacy through EURETINA and has been supported by Oculis as a lasting tribute to Professor Tadayoni, the company’s Chief Scientific Officer and a world-renowned retina specialist, who unexpectedly passed away on April 19 2024. This award aims to encourage innovative research with the potential to significantly advance the understanding and treatment of retinal diseases.
This annual award of €30,000 for research support, with an additional €5,000 for the candidate, recognizes the future generation of ophthalmologists by supporting an exceptional postgraduate scholar in retina research. Applications for this year’s award will be accepted until May 12, 2025, and the award will be announced at the opening ceremony of the EURETINA Congress in Paris on September 4-7, 2025.
“On April 19, we mark the 1-year anniversary of Prof. Tadayoni's passing, and we are deeply honored to announce our continued support for this award, commemorating the extraordinary legacy of a dear friend, leading scientist and deeply valued member of the global retina community and Oculis team," Riad Sherif, MD, Chief Executive Officer of Oculis, said in a company news release. "Prof. Tadayoni’s impact on the field of ophthalmology and our pipeline remains profound. Through this award, we carry forward his passion for scientific excellence, education and patient-centered innovation. His dedication to advancing retinal research inspires us, and the next generation of clinicians and scientists committed to transforming the lives of patients with blinding diseases.”
In September 2024 Dr. Andrea Govetto, MD, PhD, was selected as the inaugural recipient of the Ramin Tadayoni Award in 2024. Dr. Govetto, a vitreoretinal surgeon at the Oftalmico-Fatebenefratelli Hospital, ASST-Fatebenefratelli-Sacco in Milan, Italy, is developing a computational model of fluid flow and retinal tissue deformation in macular edema.
“We are proud to continue the establishment of the Ramin Tadayoni Award for a second year, honoring the memory of an extraordinary individual whose legacy continues to shape the future of retinal research and care," said Anat Loewenstein, MD, President of EURETINA. "This award stands as a tribute to Prof. Tadayoni’s remarkable contributions to ophthalmology and to his role as a mentor and deeply respected colleague. By championing excellence in retinal research and fostering the next generation of leaders in the field, we continue to uphold his vision. We are grateful to Oculis for its ongoing support in this meaningful initiative.”